Diaphragm dysfunction caused by sphingomyelinase requires the p47phox subunit of NADPH oxidase

Respiratory Physiology and Neurobiology

Volumn 205, Issue , 2015, Pages 47-52

  Bost, Elaina R ^a   Frye, Gregory S ^a   Ahn, Bumsoo ^a   Ferreira, Leonardo F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

And Nox; Force; Sphingolipids

Indexed keywords

APOCYNIN; OXIDIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P47 PHOX; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; NEUTROPHIL CYTOSOLIC FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DIAPHRAGM DISEASE; MALE; MOUSE; MUSCLE STRENGTH; MUSCLE TETANIC CONTRACTION; MUSCLE TWITCH; NONHUMAN; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; KNOCKOUT MOUSE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DIAPHRAGM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; OXIDATIVE STRESS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84909608023     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2014.10.011     Document Type: Article

References (46)

1. Andrade F.H., Reid M.B., Allen D.G., Westerblad H. Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J. Physiol. 1998, 509(Pt 2):565-575.
2. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
3. Callahan L.A., She Z.W., Nosek T.M. Superoxide, hydroxyl radical, and hydrogen peroxide effects on single-diaphragm fiber contractile apparatus. J. Appl. Physiol. 2001, 90:45-54.
4. Case A.J., Li S., Basu U., Tian J., Zimmerman M.C. Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H19-H28.
5. Clarke C.J., Wu B.X., Hannun Y.A. The neutral sphingomyelinase family: identifying biochemical connections. Adv. Enzyme Regul. 2011, 51:51-58.
6. Claus R.A., Bunck A.C., Bockmeyer C.L., Brunkhorst F.M., Losche W., Kinscherf R., Deigner H.P. Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J. 2005, 19:1719-1721.
7. Contreras F.X., Villar A.V., Alonso A., Kolesnick R.N., Goni F.M. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J. Biol. Chem. 2003, 278:37169-37174.
8. Dang P.M., Fontayne A., Hakim J., El Benna J., Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J. Immunol. 2001, 166:1206-1213.
9. Dang P.M., Stensballe A., Boussetta T., Raad H., Dewas C., Kroviarski Y., Hayem G., Jensen O.N., Gougerot-Pocidalo M.A., El-Benna J. A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J. Clin. Invest. 2006, 116:2033-2043.
10. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radical Biol. Med. 2011, 51:1289-1301.
11. Doehner W., Bunck A.C., Rauchhaus M., von Haehling S., Brunkhorst F.M., Cicoira M., Tschope C., Ponikowski P., Claus R.A., Anker S.D. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur. Heart J. 2007, 28:821-828.
12. Doughan A.K., Harrison D.G., Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 2008, 102:488-496.
13. El-Benna J., Dang P.M., Gougerot-Pocidalo M.A., Marie J.C., Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp. Mol. Med. 2009, 41:217-225.
14. Empinado H.M., Deevska G.M., Nikolova-Karakashian M., Yoo J.K., Christou D.D., Ferreira L.F. Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content. Eur. J. Heart Fail. 2014, 16:519-525.
15. Espinosa A., Garcia A., Hartel S., Hidalgo C., Jaimovich E. NADPH oxidase and hydrogen peroxide mediate insulin-induced calcium increase in skeletal muscle cells. J. Biol. Chem. 2009, 284:2568-2575.
16. Fattman C.L., Schaefer L.M., Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 2003, 35:236-256.
17. Ferreira L.F., Campbell K.S., Reid M.B. Effectiveness of sulfur-containing antioxidants in delaying skeletal muscle fatigue. Med. Sci. Sports Exerc. 2011, 43:1025-1031.
18. Ferreira L.F., Gilliam L.A., Reid M.B. L-2-oxothiazolidine-4-carboxylate reverses glutathione oxidation and delays fatigue of skeletal muscle in vitro. J. Appl. Physiol. 2009, 107:211-216.
19. Ferreira L.F., Moylan J.S., Gilliam L.A., Smith J.D., Nikolova-Karakashian M., Reid M.B. Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue. Am. J. Physiol. Cell Physiol. 2010, 299:C552-C560.
20. Ferreira L.F., Moylan J.S., Stasko S., Smith J.D., Campbell K.S., Reid M.B. Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers. J. Appl. Physiol. 2012, 112:1538-1545.
21. Garcia-Ruiz C., Colell A., Mari M., Morales A., Fernandez-Checa J.C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 1997, 272:11369-11377.
22. Giltiay N.V., Karakashian A.A., Alimov A.P., Ligthle S., Nikolova-Karakashian M.N. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes. J. Lipid Res. 2005, 46:2497-2505.
23. Gulbins E., Li P.L. Physiological and pathophysiological aspects of ceramide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R11-R26.
24. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9:139-150.
25. Heumuller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schroder K., Brandes R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217.
26. Hidalgo C., Sanchez G., Barrientos G., racena-Parks P. A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S -glutathionylation. J. Biol. Chem. 2006, 281:26473-26482.
27. Huang C.K., Zhan L., Hannigan M.O., Ai Y., Leto T.L. P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+. J. Leukoc. Biol. 2000, 67:210-215.
28. Inoue N., Kinugawa S., Suga T., Yokota T., Hirabayashi K., Kuroda S., Okita K., Tsutsui H. Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H1202-H1210.
29. Jackson S.H., Gallin J.I., Holland S.M. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 1995, 182:751-758.
30. Javesghani D., Magder S.A., Barreiro E., Quinn M.T., Hussain S.N. Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. Am. J. Respir. Crit. Care Med. 2002, 165:412-418.
31. Johnson J.L., Park J.W., Benna J.E., Faust L.P., Inanami O., Babior B.M. Activation of p47(PHOX), a cytosolic subunit of the leukocyte NADPH oxidase. Phosphorylation of ser-359 or ser-370 precedes phosphorylation at other sites and is required for activity. J. Biol. Chem. 1998, 273:35147-35152.
32. Lassegue B., San Martin A., Griendling K.K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 2012, 110:1364-1390.
33. Marchesini N., Hannun Y.A. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 2004, 82:27-44.
34. Michaelson L.P., Shi G., Ward C.W., Rodney G.G. Mitochondrial redox potential during contraction in single intact muscle fibers. Muscle Nerve 2010, 42:522-529.
35. Pal R., Basu Thakur P., Li S., Minard C., Rodney G.G. Real-time imaging of NADPH oxidase activity in living cells using a novel fluorescent protein reporter. PLoS One 2013, 8:e63989.
36. Poole D.C., Wagner P.D., Wilson D.F. Diaphragm microvascular plasma PO2 measured in vivo. J. Appl. Physiol. 1995, 79:2050-2057.
37. Powers S.K., Jackson M.J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol. Rev. 2008, 88:1243-1276.
38. Reid M.B., Moylan J.S. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J. Physiol. 2011, 589:2171-2179.
39. Sakellariou G.K., Vasilaki A., Palomero J., Kayani A., Zibrik L., McArdle A., Jackson M.J. Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activity. Antioxid. Redox. Signal. 2013, 18:603-621.
40. Semprun-Prieto L.C., Sukhanov S., Yoshida T., Rezk B.M., Gonzalez-Villalobos R.A., Vaughn C., Michael Tabony A., Delafontaine P. Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Biochem. Biophys. Res. Commun. 2011, 409:217-221.
41. Sun Q.A., Hess D.T., Nogueira L., Yong S., Bowles D.E., Eu J., Laurita K.R., Meissner G., Stamler J.S. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16098-16103.
42. Supinski G., Stofan D., Callahan L.A., Nethery D., Nosek T.M., DiMarco A. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm. J. Appl. Physiol. 1999, 87:783-791.
43. Wehrens X.H., Lehnart S.E., Reiken S., van der Nagel R., Morales R., Sun J., Cheng Z., Deng S.X., de Windt L.J., Landry D.W., Marks A.R. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9607-9612.
44. Won J.S., Singh I. Sphingolipid signaling and redox regulation. Free Radic. Biol. Med. 2006, 40:1875-1888.
45. Xia R., Webb J.A., Gnall L.L., Cutler K., Abramson J.J. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am. J. Physiol. Cell Physiol. 2003, 285:C215-C221.
46. Zhang D.X., Zou A.P., Li P.L. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H605-H612.